The pathogenesis of Barrett's esophagus (Q35198758)

7 August 2017

1 reference

title

The pathogenesis of Barrett's esophagus (English)

1 reference

7 August 2017

1 reference

2

Michael J G Farthing

1 reference

7 August 2017

Rebecca C Fitzgerald

1

1 reference

7 August 2017

publication date

1 April 2003

1 reference

Gastrointestinal endoscopy clinics of North America

7 August 2017

published in

1 reference

7 August 2017

volume

13

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

233-255

1 reference

Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: Delineation of epithelial phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

1 reference

7 January 2021

Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Gastroesophageal reflux disease in monozygotic and dizygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Is there a GERD gene?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Familial clustering of reflux symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Is Barrett's metaplasia the source of adenocarcinomas of the cardia?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Classification of adenocarcinoma of the oesophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Adenocarcinoma of the esophagus and/or gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Helicobacter pylori infection and the risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Gene expression profiling in human esophageal cancers using cDNA microarray.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Gastrointestinal epithelial neoplasia: Vienna revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Evolution of neoplastic cell lineages in Barrett oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cell proliferation in three types of Barrett's epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Replication licensing--defining the proliferative state?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

MCM proteins in DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Improved cervical smear assessment using antibodies against proteins that regulate DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Interphase Cytogenetics of Esophageal Adenocarcinoma and Precursor Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Abnormal expression of growth regulatory factors in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Abnormal expression of the E-cadherin-catenin complex in dysplastic Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Expression of cyclin E in dysplasia, carcinoma, and nonmalignant lesions of Barrett esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Association between body mass and adenocarcinoma of the esophagus and gastric cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Re: Adenocarcinoma of the esophagus: role of obesity and diet

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

A case-control study of oesophageal adenocarcinoma in women: a preventable disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Potential genotoxicity of chronically elevated nitric oxide: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Carcinogenesis at the gastroesophageal junction: free radicals at the frontier

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Association between cholecystectomy and adenocarcinoma of the esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Regulation of intracellular pH in eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Intracellular p H of Mitogen-Stimulated Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Changes in intracellular pH of Physarum plasmodium during the cell cycle and in response to starvation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Inflammatory gradient in Barrett's oesophagus: implications for disease complications

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

1 reference

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cyclooxygenase-2: regulation and relevance in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cyclooxygenase-2 expression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Complete Elimination of Reflux Symptoms Does Not Guarantee Normalization of Intraesophageal Acid Reflux in Patients With Barrett's Esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Effect of antireflux operation on Barrett's mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5157%2803%2900007-2

7 January 2021

10.1016/S1052-5157(03)00007-2

Identifiers

DOI

1 reference

7 August 2017

1 reference